logo
16:01 Jun 25

Beryl Drugs Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
23.50
+1.32 (+5.95%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Beryl Drugs Ltd. Financials

Beryl Drugs Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
23.50
+1.32 (+5.95%)
16:01 Jun 25
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

54/100
Affordable Valuation

Technical

47/100
Technically Neutral

Strength

9

Weakness

6

Opportunity

0

Threats

0

4.29 %

ROE %

0.00 %

ROA %

0.00

EPS

0.00

BVPS

6.21 %

Net Profit Margin

Mar 2017 Mar 2018
Net Sales
11.53 15.99
Operating Expenses +
11.31 14.3
Raw Material
6.94 8.91
Increase Decrease in Cost
-0.45 0.45
Other Manufacturing Expense
0 0
Employee Cost
0.98 0.73
Miscellaneous Expenses
3.84 4.21
Operating Profit
0.22 1.69
Other Income
0 0
Depreciation
0.38 0.33
Interest
0.2 0.13
Profit before tax and exceptio..
-0.36 1.23
Exceptional Items
0 0
PBT
-0.36 1.23
Provision for Taxation
0.05 0.23
Net Profit
-0.41 0.99
NET Profit after MI
-0.41 0.99
EPS
0 1.96
Operating Profit Margin (%)
1.91 10.57
Net Profit Margin (%)
-3.56 6.19

Beryl Drugs Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: